JPWO2022266511A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022266511A5 JPWO2022266511A5 JP2023577464A JP2023577464A JPWO2022266511A5 JP WO2022266511 A5 JPWO2022266511 A5 JP WO2022266511A5 JP 2023577464 A JP2023577464 A JP 2023577464A JP 2023577464 A JP2023577464 A JP 2023577464A JP WO2022266511 A5 JPWO2022266511 A5 JP WO2022266511A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- virus
- viral antigen
- nucleotide sequence
- viruses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163211974P | 2021-06-17 | 2021-06-17 | |
| US63/211,974 | 2021-06-17 | ||
| US202163240278P | 2021-09-02 | 2021-09-02 | |
| US63/240,278 | 2021-09-02 | ||
| US202163275398P | 2021-11-03 | 2021-11-03 | |
| US63/275,398 | 2021-11-03 | ||
| PCT/US2022/034104 WO2022266511A1 (en) | 2021-06-17 | 2022-06-17 | Temperature-controllable, self-replicating rna vaccines for viral diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024523329A JP2024523329A (ja) | 2024-06-28 |
| JP2024523329A5 JP2024523329A5 (https=) | 2025-06-10 |
| JPWO2022266511A5 true JPWO2022266511A5 (https=) | 2025-06-10 |
Family
ID=84526756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023577464A Pending JP2024523329A (ja) | 2021-06-17 | 2022-06-17 | ウイルス性疾患用の温度制御可能な自己複製ｒｎａワクチン |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240269268A1 (https=) |
| EP (1) | EP4355880A4 (https=) |
| JP (1) | JP2024523329A (https=) |
| KR (1) | KR20240023600A (https=) |
| AU (1) | AU2022294919A1 (https=) |
| CA (1) | CA3221347A1 (https=) |
| IL (1) | IL309038A (https=) |
| MX (1) | MX2023014564A (https=) |
| WO (1) | WO2022266511A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117003835A (zh) * | 2023-03-17 | 2023-11-07 | 成都威斯克生物医药有限公司 | 抗SARS-CoV-2奥密克戎突变株XBB及其亚型感染的蛋白及疫苗 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017015457A1 (en) * | 2015-07-21 | 2017-01-26 | Modernatx, Inc. | Ebola vaccine |
| EP3558356A2 (en) * | 2016-12-23 | 2019-10-30 | CureVac AG | Mers coronavirus vaccine |
| MA47790A (fr) * | 2017-03-17 | 2021-05-05 | Modernatx Inc | Vaccins à base d'arn contre des maladies zoonotiques |
| WO2021138447A1 (en) * | 2019-12-31 | 2021-07-08 | Elixirgen Therapeutics, Inc. | Temperature-based transient delivery of nucleic acids and proteins to cells and tissues |
| WO2021222228A1 (en) * | 2020-04-27 | 2021-11-04 | Ohio State Innovation Foundation | A live attenuated measles virus vectored vaccine for sars-cov-2 |
| BR112022025653A2 (pt) * | 2020-06-19 | 2023-03-07 | Ziphius Vaccines | Vacina autoamplificante de rna sars-cov-2 |
-
2022
- 2022-06-17 KR KR1020247001316A patent/KR20240023600A/ko active Pending
- 2022-06-17 EP EP22825942.0A patent/EP4355880A4/en active Pending
- 2022-06-17 MX MX2023014564A patent/MX2023014564A/es unknown
- 2022-06-17 AU AU2022294919A patent/AU2022294919A1/en active Pending
- 2022-06-17 IL IL309038A patent/IL309038A/en unknown
- 2022-06-17 JP JP2023577464A patent/JP2024523329A/ja active Pending
- 2022-06-17 US US18/569,589 patent/US20240269268A1/en active Pending
- 2022-06-17 WO PCT/US2022/034104 patent/WO2022266511A1/en not_active Ceased
- 2022-06-17 CA CA3221347A patent/CA3221347A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4253403A2 (en) | Zika virus purification | |
| JPWO2021239880A5 (https=) | ||
| WO2024114542A1 (zh) | 痘病毒多抗原嵌合疫苗及其用途 | |
| Matveeva et al. | Mechanisms of oncolysis by paramyxovirus Sendai | |
| US6828138B1 (en) | Recombinant sendai virus vector including a gene encoding a chemokine | |
| WO2024140767A1 (zh) | 用于预防或治疗hpv感染相关疾病的多核苷酸分子 | |
| WO2023051701A1 (zh) | 抗SARS-CoV-2感染的mRNA、蛋白以及抗SARS-CoV-2感染的疫苗 | |
| US20250339511A1 (en) | Nucleic acid vaccine against monkeypox virus and use thereof | |
| CN112439058A (zh) | 基于外泌体为载体的重组新型冠状病毒纳米疫苗方法 | |
| CN113430178B (zh) | 一种表达ii型单纯疱疹病毒蛋白的重组流感病毒株及其制备方法与应用 | |
| CN101768211A (zh) | 新城疫病毒Italien株HN蛋白和F蛋白及其在基因治疗药物中的应用 | |
| JPWO2020065349A5 (https=) | ||
| JPWO2022266511A5 (https=) | ||
| JP5884100B2 (ja) | 新型インフルエンザウイルス由来ヘマグルチニンタンパク質遺伝子を有するＤＩｓ株由来組換えワクシニアウイルス | |
| JP4797149B2 (ja) | インフルエンザウイルスに対するベクターワクチン | |
| US20160228531A1 (en) | Treatment of hepatitis d virus infections by redirection of t cells | |
| Murakami et al. | Newly‐developed Sendai virus vector for retinal gene transfer: reduction of innate immune response via deletion of all envelope‐related genes | |
| CN101394868A (zh) | 重组腺病毒5型/35型和痘病毒mva活病毒载体疫苗的联用诱导强大的免疫应答的方法 | |
| WO2022245287A1 (en) | Amino acids, nucleotides and vectors expressing the same and uses thereof in preventing sarbecovirus infection | |
| Satapathy et al. | Developmental biology of Corona vaccine: lipid nanoparticle mRNA-encapsulation, a safe approach. | |
| Bakhuraysah | Immunity and therapeutic approaches against coronavirus disease 2019 | |
| Zhang et al. | Harnessing T Cells: Cellular Immunity’s Role in Vaccine Induced Protection | |
| JPWO2021198701A5 (https=) | ||
| JP5699093B2 (ja) | パラポックスウイルス・オヴィスの組換えタンパク質およびそれ由来の医薬組成物 | |
| CN110204613A (zh) | 一种针对胡宁病毒的中和抗体、其制备方法及其应用 |